Risk Assessment of Cardiovascular Disease in HIV Infected Individuals Receiving Antiretroviral Therapy - Shanghai Municipality, China, 2023.

IF 2.9 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 中国疾病预防控制中心周报 Pub Date : 2025-02-21 DOI:10.46234/ccdcw2025.043

Xiaomeng Li, Lin Wang, Li Liu, Zihui Zhao, Ye Li, Jiawei Huang, Huiqin Yan, Yiping Jin, Meiyan Sun, Jun Chen, Yingying Ding, Renfang Zhang, Yinzhong Shen

{"title":"Risk Assessment of Cardiovascular Disease in HIV Infected Individuals Receiving Antiretroviral Therapy - Shanghai Municipality, China, 2023.","authors":"Xiaomeng Li, Lin Wang, Li Liu, Zihui Zhao, Ye Li, Jiawei Huang, Huiqin Yan, Yiping Jin, Meiyan Sun, Jun Chen, Yingying Ding, Renfang Zhang, Yinzhong Shen","doi":"10.46234/ccdcw2025.043","DOIUrl":null,"url":null,"abstract":"What is already known about this topic?: Antiretroviral therapy (ART) is transforming human immunodeficiency virus (HIV) infection into a chronic condition, leading to an altered disease spectrum in patients. The risk of cardiovascular disease (CVD) in HIV-infected individuals are twice that of the general population.What is added by this report?: This study demonstrates elevated cardiovascular risk among the HIV population. The findings reveal that traditional CVD risk factors are prevalent among people living with HIV but remain inadequately addressed in clinical practice.What are the implications for public health practice?: These findings underscore both the necessity and urgency of implementing systematic CVD risk screening and intervention programs for HIV population. Furthermore, the study emphasizes the critical need to develop CVD screening tools specifically calibrated for the HIV population in China.","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"7 8","pages":"271-276"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11911657/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国疾病预防控制中心周报","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.46234/ccdcw2025.043","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

What is already known about this topic?: Antiretroviral therapy (ART) is transforming human immunodeficiency virus (HIV) infection into a chronic condition, leading to an altered disease spectrum in patients. The risk of cardiovascular disease (CVD) in HIV-infected individuals are twice that of the general population.

What is added by this report?: This study demonstrates elevated cardiovascular risk among the HIV population. The findings reveal that traditional CVD risk factors are prevalent among people living with HIV but remain inadequately addressed in clinical practice.

What are the implications for public health practice?: These findings underscore both the necessity and urgency of implementing systematic CVD risk screening and intervention programs for HIV population. Furthermore, the study emphasizes the critical need to develop CVD screening tools specifically calibrated for the HIV population in China.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

接受抗逆转录病毒治疗的HIV感染者心血管疾病风险评估——上海市，中国，2023。

关于这个话题我们已经知道了什么？抗逆转录病毒疗法（ART）正在将人类免疫缺陷病毒（HIV）感染转化为一种慢性疾病，导致患者的疾病谱发生改变。艾滋病毒感染者患心血管疾病（CVD）的风险是一般人群的两倍。这份报告增加了什么内容？这项研究表明，在HIV人群中心血管风险升高。研究结果表明，传统的心血管疾病风险因素在艾滋病毒感染者中普遍存在，但在临床实践中仍未得到充分解决。这对公共卫生实践有什么影响？这些发现强调了在HIV人群中实施系统的心血管疾病风险筛查和干预计划的必要性和紧迫性。此外，该研究强调了开发专门针对中国艾滋病毒人群的心血管疾病筛查工具的迫切需要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

中国疾病预防控制中心周报

CiteScore

5.90

自引率

0.00%

发文量